Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo

Clinical Cancer Research

Volumn 11, Issue 2 I, 2005, Pages 806-813

  Sarti, Manuela ^a   Sevignani, Cinzia ^a   Calin, George A ^a   Aqeilan, Rami ^a   Shimizu, Masayoshi ^a   Pentimalli, Francesca ^a   Picchio, Maria Cristina ^a   Godwin, Andrew ^b   Rosenberg, Anne ^c   Drusco, Alessandra ^a   Negrini, Massimo ^d   Croce, Carlo M ^a,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF FERRARA   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL ASSAY; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMOSOME 7Q; COLON CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIN GENE; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UTERUS CANCER; UTERUS SARCOMA; VIRAL GENE THERAPY; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; COLONIC NEOPLASMS; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, NUDE; SARCOMA, EXPERIMENTAL; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UTERINE NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 19944428406     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tatarelli C, Linnenbach A, Mimori K, Croce CM. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics 2000;68:1-12.
2. Tobias ES, Hurlstone AFL, MacKenzie E, McFarlane R, Black DM. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 2001;20:2844-53.
3. Huang H, Qian C, Jenkins RB, Smith DI. Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACs spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer 1998;21:152-9.
4. Razani B, Schlegel A, Liu J, Lisanti MP. Caveolin-I, a putative tumour suppressor. Biochem Soc Trans 2001;29:494-9.
5. Engelman JA, Zhang XL, Lisanti MP. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett 1998;436:403-10.
6. Lin JC, Scherer SW, Tougas L, et al. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. Oncogene 1996;13:2001-8.
7. Coutts AS, MacKenzie E, Griffith E, Black DM. TES is a novel focal adhesion protein with a role in cell spreading. J Cell Sci 2003; 116:897-906.
8. Ausubel FM, Brent R, Kingston M, et al. Analysis of proteins. In: Current protocols in molecular biology. New York: Wiley-Interscience, 1989. p. 10.1-10.20.
9. Aqeilan R, Yarkoni S, Lorberboum-Galski H. Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy. FEBS Lett 1999;457:271-6.
10. Madsen M, Briand P. Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines. Cancer 1990;26:793-7.
11. 1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 2003;63:1846-52.
12. Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998;273:9357-60.
13. Liang Y, Yan C, Schor NF. Apoptosis in the absence of caspase-3. Oncogene 2001;20:6570-8.
14. Shankar SL, Mani S, O'Guin KN, Kandimalla ER, Agrawal S, Shafit-Zagardo B. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem 2001;79:426-36.
15. Ahn HJ, Kim YS, Kim JU, Man SM, Shin JW, Yang HO. Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem 2004;91:1043-52.
16. J6. Liu T, Brouha B, Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004;23:39-48.
17. Couch FJ, Weber BL. Breast cancer. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 1998. p. 537-63.
18. Chauveinc L, Deniaud E, Plancher C, et al. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 1999;72:232-7.
19. Le T. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population. Eur J Surg Oncol 2001;27:282-5.
20. Garvalov BK, Higging TE, Sutherland JD, et al. The conformational state of TES regulates its zyxin-dependent recruitment to focal adhesions. J Cell Biol 2003;161:33-9.
21. Bach I. The LIM domain: regulation by association. Mech Dev 2000;91:5-17.
22. Macalma T, Otte J, Hensler ME, et al. Molecular characterization of human zyxin. J Biol Chem 1996;271:31470-8.
23. van Gurp M, Festjens N, van Loo G, Saelens X, Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003;304:487-97.
24. Candè C, Vahsen N, Garrido C, Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ 2004;11: 591-5.